These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10958592)

  • 1. Phase II study of intravenous Doxil in malignant pleural mesothelioma.
    Oh Y; Perez-Soler R; Fossella FV; Glisson BS; Kurie J; Walsh GL; Truong M; Shin DM
    Invest New Drugs; 2000 Aug; 18(3):243-5. PubMed ID: 10958592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task Force.
    Pennucci MC; Ardizzoni A; Pronzato P; Fioretti M; Lanfranco C; Verna A; Giorgi G; Vigani A; Frola C; Rosso R
    Cancer; 1997 May; 79(10):1897-902. PubMed ID: 9149015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
    Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
    Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caelyx in malignant mesothelioma: a phase II EORTC study.
    Baas P; van Meerbeeck J; Groen H; Schouwink H; Burgers S; Daamen S; Giaccone G
    Ann Oncol; 2000 Jun; 11(6):697-700. PubMed ID: 10942058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of pegylated-liposomal doxorubicin (Doxil) in mesothelioma.
    Skubitz KM
    Cancer Invest; 2002; 20(5-6):693-9. PubMed ID: 12197225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of doxorubicin versus cyclophosphamide in diffuse malignant pleural mesothelioma.
    Sørensen PG; Bach F; Bork E; Hansen HH
    Cancer Treat Rep; 1985 Dec; 69(12):1431-2. PubMed ID: 3907825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of malignant pleural mesothelioma with liposomized doxorubicine: prolonged time to progression and good survival. A Nordic study.
    Hillerdal G; Sorensen JB; Sundström S; Vikström A; Hjerpe A
    Clin Respir J; 2008 Apr; 2(2):80-5. PubMed ID: 20298311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP).
    Parra HS; Tixi L; Latteri F; Bretti S; Alloisio M; Gravina A; Lionetto R; Bruzzi P; Dani C; Rosso R; Cosso M; Balzarini L; Santoro A; Ardizzoni A
    Cancer; 2001 Aug; 92(3):650-6. PubMed ID: 11505411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma.
    Steele JP; O'Doherty CA; Shamash J; Evans MT; Gower NH; Tischkowitz MD; Rudd RM
    Ann Oncol; 2001 Apr; 12(4):497-9. PubMed ID: 11398882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of pirarubicin in malignant pleural mesothelioma.
    Kaukel E; Koschel G; Gatzemeyer U; Salewski E
    Cancer; 1990 Aug; 66(4):651-4. PubMed ID: 2386894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An Italian Lung Cancer Task Force (FONICAP) Phase II study.
    Ardizzoni A; Rosso R; Salvati F; Fusco V; Cinquegrana A; De Palma M; Serrano J; Pennucci MC; Soresi E; Crippa M
    Cancer; 1991 Jun; 67(12):2984-7. PubMed ID: 2044044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B.
    Kindler HL; Herndon JE; Zhang C; Green MR;
    Lung Cancer; 2005 Jun; 48(3):423-8. PubMed ID: 15893012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of remission induced in diffuse pleural malignant mesothelioma by the treatment with cisplatin and doxorubicin].
    Niki Y; Nakayama S; Soga T; Baba M; Nishimura A; Kato M; Kanamaru M
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3635-8. PubMed ID: 2817912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients.
    Porta C; Zimatore M; Bonomi L; Imarisio I; Paglino C; Sartore-Bianchi A; Mutti L
    Lung Cancer; 2005 Jun; 48(3):429-34. PubMed ID: 15893013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A diffuse, pleural, malignant mesothelioma kept in long remission by chemotherapy combining pirarubicin and cisplatin].
    Niki Y; Soga T; Nishimura A; Kato M; Hamada M; Kanamaru M
    Gan No Rinsho; 1990 Nov; 36(14):2463-7. PubMed ID: 2250368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin, mitomycin, and interferon-alpha2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma.
    Metintas M; Ozdemir N; Uçgun I; Elbek O; Kolsuz M; Mutlu S; Metintas S
    Chest; 1999 Aug; 116(2):391-8. PubMed ID: 10453867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma.
    Berghmans T; Lafitte JJ; Paesmans M; Stach B; Berchier MC; Wackenier P; Lecomte J; Collon T; Mommen P; Sculier JP;
    Lung Cancer; 2005 Oct; 50(1):75-82. PubMed ID: 16005104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of acivicin in malignant mesothelioma.
    Falkson G; Vorobiof DA; Simson IW; Borden EC
    Cancer Treat Rep; 1987 May; 71(5):545-6. PubMed ID: 3567981
    [No Abstract]   [Full Text] [Related]  

  • 19. Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group.
    van Meerbeeck J; Debruyne C; van Zandwijk N; Postmus PE; Pennucci MC; van Breukelen F; Galdermans D; Groen H; Pinson P; van Glabbeke M; van Marck E; Giaccone G
    Br J Cancer; 1996 Sep; 74(6):961-3. PubMed ID: 8826866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase-II study with the combination of cisplatin and doxorubicin in advanced malignant mesothelioma of the pleura.
    Henss H; Fiebig HH; Schildge J; Arnold H; Hasse J
    Onkologie; 1988 Jun; 11(3):118-20. PubMed ID: 3045724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.